Effect of Probenecid on Pharmacokinetics and Tolerability of Olmesartan in Healthy Chinese Volunteers

• Principais autores: Kun-Yan Li, PhD (Autor), Yu Qiu, MS (Autor), Yun Jiang, BS (Autor), Chen-Hui Luo, MS (Autor), Xiao-Ping Lin, BS (Autor), Jing Wang, BS (Autor), Nong Yang, MS (Autor)
• Formato: Livro
• Publicado em: Elsevier, 2014-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Olmesartan is an angiotensin II receptor antagonist and is effective and well tolerated in the treatment of arterial hypertension. Probenecid is a well-established hypouricemic agent for the treatment of hyperuricemia and gout. Objective: The goal of this study was to examine the impact...